ClinConnect ClinConnect Logo
Search / Trial NCT05089799

" Socially Pertinent Robot in Gerontological Healthcare "

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Oct 11, 2021

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Socially Assistive Robots Gerontological Healthcare Acceptance Usability Organizational And Ethic Impact

ClinConnect Summary

The SPRING project is a clinical trial aimed at developing a social assistance robot named ARI, designed to help patients, their families, and healthcare workers in busy hospital settings. ARI will interact with users by providing information, guidance, and entertainment, while also supporting care staff. The researchers want to understand how people respond to and use this robot in a day care hospital environment.

To participate in this study, patients must be at least 60 years old, speak some French, and be able to engage with the robot without any serious confusion or memory issues. Accompanying adults and healthcare professionals over 18 who understand French can also join. Participants will be asked for their consent to be involved and to interact with the robot. The trial is currently recruiting, and it’s important to note that those who do not wish to participate or have specific medical conditions will not be included in the study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • PATIENTS
  • Age 60 and over
  • Enough knowledge in French language
  • Without distinction of gender, socio-professional categories or ethnic origin
  • MMSE \> 10
  • No symptoms of altered reality (delirium, hallucination, frontal disinhibition, etc.).
  • Having expressed his/her non-opposition to his/her participation in the study or to being in the presence of the robot
  • If the persons are protected adults under guardianship, the tutor or legal guardian has expressed his/her non-opposition to participate in the study or to be in the presence of the robot for the person concerned.
  • ACCOMPANYING PERSONS
  • They are all adults who have enough knowledge in French language.
  • They are enrolled without distinction of gender, socio-professional categories or ethnic origin
  • They have expressed his/her non-opposition to participate in the study
  • * PROFESSIONALS:
  • Age 18 and over.
  • Has expressed his/her non-opposition to participate in the study
  • Exclusion Criteria:
  • PATIENTS
  • They have expressed, or where applicable, their family, guardian or legal representative, their opposition to participate in the study or their opposition to be in the presence of the robot.
  • PAtients benefiying of Medical State Aid (French AME)
  • ACCOMPANYING PERSONS They are under 18. They do not have enough knowledge in French language to understand simple instructions. They have expressed their opposition to participate in the study or their opposition to be in the presence of the robot.
  • PROFESSIONNALS They have expressed their opposition to participate in the study or their opposition to be in the presence of the robot.

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Paris, Ile De France, France

Patients applied

0 patients applied

Trial Officials

RIGAUD Anne-Sophie

Principal Investigator

Assistance Publique - Hôpitaux de Paris

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials